Neurological disorders associated with patent foramen ovale

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The foramen ovale between the right and left atria remains open in 15–25% of people over 18 years of age and in most of them it does not manifest itself clinically. At the same time, the defect is associated with a number of diseases and conditions: the development of atrial fibrillation, worsening the degree of hypoxemia in patients with pulmonary diseases, etc. There are studies devoted to the influence of a patent foramen ovale on the occurrence and course of cryptogenic stroke, migraine, syncope, dizziness, transient global amnesia, visual impairment and ocular movement disorders. However, the actual contribution of patent foramen ovale to the development of neurological disorders remains a matter of debate. The purpose of this work was to assess the significance of a patent foramen ovale in the development of neurological disorders in adults and children by analyzing literature data for the period from 2012 to 2022. In the process of studying the literature, a high prevalence of the defect was identified among patients with stroke and migraine (especially migraine with aura). At the same time, data from randomized clinical trials in patients with stroke and migraine showed selectively high effectiveness of closure of the patent foramen ovale in certain groups of patients. The association of patent foramen ovale with transient global amnesia, syncope, and dizziness has been confirmed in a limited number of studies. Cases of visual impairment and ocular movement disorders associated with the presence of a patent foramen ovale have been described. Thus, it was concluded that a patent foramen ovale is a risk factor for the development of neurological disorders only in certain groups of patients with stroke and migraine. The connection between the defect and the development of transient global amnesia, syncope, dizziness, visual impairment, as well as the development of neurological pathology in children requires further research.

About the authors

Polina D. Perevezentseva

Kazan State Medical University

Email: pperevezentseva@list.ru
ORCID iD: 0009-0002-9210-8192

student

Russian Federation, Kazan

Dina D. Gaynetdinova

Kazan State Medical University

Author for correspondence.
Email: anetdina@mail.ru
ORCID iD: 0000-0002-4255-9107

M.D., D. Sci. (Med.), Prof., Depart. of Neurology

Russian Federation, Kazan

References

  1. Ning MM., Lo EH, Ning P-H, Xu S-Y, McMullin D, Demirjian Z, Inglessis I, Dec GW, Palacios I, Ferdinando S, Buonanno FS. The brain's heart — Therapeutic opportunities for patent foramen ovale (PFO) and neurovascular disease. Pharmacol Ther. 2013;139(2):111–123. doi: 10.1016/j.pharmthera.2013.03.007.
  2. Nakanishi K, Yoshiyama M, Homma S. Patent foramen ovale and cryptogenic stroke. Trends Cardiovasc Med. 2017;27(8):575–581. doi: 10.1016/j.tcm.2017.06.016.
  3. Abdelghani M, El-Shedoudy SAO, Nassif M, Bouma BJ, de Winter RJ. Management of patients with patent foramen ovale and cryptogenic stroke: An update. Cardiology. 2019;143(1–2):62–72. doi: 10.1159/000501028.
  4. Mojadidi MK, Ruiz JC, Chertoff J, Zaman MO, Elgendy IY, Mahmoud AN, Al-Ani M, Elgendy AY, Patel NK, Shantha G, Tobis JM, Meier B. Patent foramen ovale and hypoxemia. Cardiol Rev. 2019;27(1):34–40. doi: 10.1097/CRD.0000000000000205.
  5. Cheaito R, Benamer H, Tritar A, Hage F, Haziza F, Piechaud JF, El-Amine S, Medkour F, Morice MC. Platypnea-orthodeoxia revealed by recurrent syncope episodes. Ann Cardiol Angeiol (Paris). 2014;63(6):451–454. doi: 10.1016/j.ancard.2014.09.040.
  6. Klein MR, Kiefer TL, Velazquez EJ. Platypnea-orthodeoxia syndrome: To shunt or not to shunt, that is the question. Tex Heart Inst J. 2016;43(3):264–266. doi: 10.14503/THIJ-15-5280.
  7. Silalahi TDA, Suwita CS, Darmawan RO, Rosalie B. Diagnosing and treating Patent Foramen Ovale (PFO) from various manifestations in adults: Case series. Bali Medical Journal. 2022;11(1):405–409. doi: 10.15562/bmj.v11i1.2779.
  8. Kang M-K, Kim SY, Kang HG, Shin B-S, Lee C-H. Transient global amnesia caused by cryptogenic ischemic stroke. Interdisciplinary Neurosurgery. 2021;23(100911):2214–7519 doi: 10.1016/j.inat.2020.100911.
  9. Grudzińska E, Nowacka B, Bania B, Lubiński W, Zaborski D, Modrzejewska M. Patent foramen ovale as a cause of acute vision loss. Int J Ophthalmol. 2021;14(7):1125–1126. doi: 10.18240/ijo.2021.07.25.
  10. Zhu L, Xu N, Li Y. Monocular central retinal artery occlusion caused by bilateral internal carotid artery hypoplasia complicated with patent foramen ovale: A case report and review of literature. Eur J Med Res. 2021;26:55. doi: 10.1186/s40001-021-00530-w.
  11. De Pinho Tavares PR, de Oliveira MR, de Castro Miranda Diniz E, Agostini RM, de Aguiar DV. Central retinal artery occlusion associated with patent foramen ovale. Revista Brasileira de Oftalmologia. 2014;73(5):308–310. doi: 10.5935/0034-7280.20140065.
  12. Liu X, Calvert PA, Arif S, Keane PA, Denniston AK. Patent foramen ovale presenting as visual loss. JRSM Open. 2017;8(1). doi: 10.1177/2054270416669302.
  13. Shoeibi N, Poorzand H, Abrishami M. Branch retinal artery occlusion in a patient with patent foramen ovale. J Ophthalmic Vis Res. 2013;8(1):58–61. PMID: 23825714.
  14. Khan AO. Pupil-sparing complete third nerve palsy from cryptogenic midbrain stroke in an otherwise-healthy young adult with patent foramen ovale. Middle East Afr J Ophthalmol. 2012;19(2):237–239. doi: 10.4103/0974-9233.95260.
  15. Xie Drs N, Sun Q. Bilateral ptosis caused by patent foramen ovale-associated stroke. QJM. 2022;115(12):853–854. doi: 10.1093/qjmed/hcac196.
  16. Wenfei С, Yinbo S, Jiaqi Z, Zhenhong C, Nizhuan W, Jiajun Y. The patent foramen ovale and migraine: Associated mechanisms and perspectives from MRI evidence. Brain Sci. 2022;12(7):941. doi: 10.3390/brainsci12070941.
  17. Hildick-Smith D, Williams TM. Patent foramen ovale and migraine headache. Interv Cardiol Clin. 2017;6(4):539–545. doi: 10.1016/j.iccl.2017.05.006.
  18. Quinette P, Constans JM, Hainselin M, Desgranges B, Eustache F, Viader F. Hippocampal modifications in transient global amnesia. Rev Neurol (Paris). 2015;171(3):282–288. doi: 10.1016/j.neurol.2015.01.003.
  19. Liu D, Chen K, Gong J, Huang L, Dong X, Wan Q, Qin X, Shi J, Zhang L, Wang Z. Right-to-left shunts in unexplained syncope: An age- and sex-matched case-control study. Quant Imaging Med Surg. 2022;12(7):3592–3602. doi: 10.21037/qims-21-1060.
  20. Cao Q, Shen Y, Hou Z, Li D, Tang B, Xu L, Li Y. The relationship between patent foramen ovale and unexplained dizziness: A prospective analysis in China. Neuropsychiatr Dis Treat. 2022;26(18):1495–1505. doi: 10.2147/NDT.S367140.
  21. Leong MC, Uebing A, Gatzoulis MA. Percutaneous patent foramen ovale occlusion: Current evidence and evolving clinical practice. Int J Cardiol. 2013;169(4):238–243. doi: 10.1016/j.ijcard.2013.08.095.
  22. Miranda B, Fonseca AC, Ferro JM. Patent foramen ovale and stroke. J Neurol. 2018;265:1943–1949. doi: 10.1007/s00415-018-8865-0.
  23. Melkumova E, Thaler DE. Cryptogenic stroke and patent foramen ovale risk assessment. Interv Cardiol Clin. 2017;6(4):487–493. doi: 10.1016/j.iccl.2017.05.005.
  24. Kent DM, Ruthazer R, Weimar C, Mas JL, Serena J, Homma S, Di Angelantonio E, Di Tullio MR, Lutz JS, Elkind MS, Griffith J, Jaigobin C, Mattle HP, Michel P, Mono ML, Nedeltchev K, Papetti F, Thaler DE. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology. 2013;81(7):619–625. doi: 10.1212/WNL.0b013e3182a08d59.
  25. Prefasi D, Martínez-Sánchez P, Fuentes B, Díez-Tejedor E. The utility of the RoPE score in cryptogenic stroke patients ≤50 years in predicting a stroke-related patent foramen ovale. Int J Stroke. 2016;11(1):7–8. doi: 10.1177/1747493015607505.
  26. Morais LA, Sousa L, Fiarresga A, Martins JD, Timóteo AT, Monteiro AV, Soares C, Agapito A, Pinto F, Ferreira RC. RoPE score as a predictor of recurrent ischemic events after percutaneous patent foramen ovale closure. Int Heart J. 2018;59(6):1327–1332. doi: 10.1536/ihj.17-489.
  27. Strambo D, Sirimarco G, Nannoni S, Perlepe K, Ntaios G, Vemmos K, Michel P. Embolic stroke of undetermined source and patent foramen ovale: Risk of paradoxical embolism score validation and atrial fibrillation prediction. Stroke. 2021;52(5):1643–1652. doi: 10.1161/STROKEAHA.120.032453.
  28. Favilla CG, Messé SR. Patent foramen ovale and stroke: Current evidence and treatment options. Curr Opin Neurol. 2020;33(1):10–16. doi: 10.1097/WCO.0000000000000782.
  29. Shih EK, Beslow LA, Natarajan SS, Falkensammer CB, Messé SR, Ichord RN. Prevalence of patent foramen ovale in a cohort of children with cryptogenic ischemic stroke. Neurology. 2021;97(21):2096–2102. doi: 10.1212/WNL.0000000000012892.
  30. Shih EK, Natarajan SS, Falkensammer CB, Beslow LA, Messé SR, Ichord RN. Abstract 170: Role of patent foramen ovale in first and recurrent childhood cryptogenic arterial ischemic stroke. Stroke. 2017;48:А170. doi: 10.1161/str.48.suppl_1.170.
  31. Menon SC, Grove A, McFadden M, Korgenski KE, Cowley CG. Clinical practice, resource utilization, and outcomes of device closure of patent foramen ovale in pediatrics. Pediatr Neurol. 2013;50(3):213–217. doi: 10.1016/j.pediatrneurol.2013.11.007.
  32. Zhang Y, Wang H, Liu L. Patent foramen ovale closure for treating migraine: A meta-analysis. J Interv Cardiol. 2022;2022:7. doi: 10.1155/2022/6456272.
  33. Liu K, Wang BZ, Hao Y, Song S, Pan M. The correlation between migraine and patent foramen ovale. Front Neurol. 2020;11:543485. doi: 10.3389/fneur.2020.543485.
  34. Kuzhel DA, Matyushin GV, Savchenko EA. Problems of diagnosis PFO. Siberian medical review. 2014;(1):70–75. (In Russ.) EDN: SCFFSL.
  35. Kumar P, Kijima Y, West BH, Tobis JM. The connection between patent foramen ovale and migraine. Neuroimaging Clin N Am. 2019;29(2):261–270. doi: 10.1016/j.nic.2019.01.006.
  36. Dowson A, Mullen MJ, Peatfield R, Muir K, Khan AA, Wells C, Lipscombe SL, Rees T, De Giovanni JV, Morrison WL, Hildick-Smith D, Elrington G, Hillis WS, Malik IS, Rickards A. Migraine Intervention with STARFlex Technology (MIST) trial: A prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation. 2008;117(11):1397–1404. doi: 10.1161/CIRCULATIONAHA.107.727271.
  37. Tobis JM, Charles A, Silberstein SD, Sorensen S, Maini B, Horwitz PA, Gurley JC. Percutaneous closure of patent foramen ovale in patients with migraine: The PREMIUM trial. J Am Coll Cardiol. 2017;70(22):2766–2774. doi: 10.1016/j.jacc.2017.09.1105.
  38. Mattle HP, Evers S, Hildick-Smith D, Becker WJ, Baumgartner H, Chataway J, Gawel M, Göbel H, Heinze A, Horlick E, Malik I, Ray S, Zermansky A, Findling O, Windecker S, Meier B. Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial. Eur Heart J. 2016;37(26):2029–2036. doi: 10.1093/eurheartj/ehw027.
  39. Choi DY, Shin DH, Cho KH, Lee SP, Park S. Migraine with aura: A predictor of patent foramen ovale in children and adolescents. Cephalalgia. 2013;33(7):463–468. doi: 10.1177/0333102413477740.
  40. McCandless RT, Arrington CB, Nielsen DC, Bale JF, Minich LL. Patent foramen ovale in children with migraine headaches. J Pediatr. 2011;159(2):243–247. doi: 10.1016/j.jpeds.2011.01.062.
  41. Bova AA, Rudoy AS, Nekhaychik TA. Patent foramen ovale: problems of diagnosis and expertise. Meditsinskie novosti. 2017;(4):4–9. (In Russ.) EDN: YMHPHT.
  42. Noh SM, Kang HG. Clinical manifestation and imaging characteristics of transient global amnesia: Patent foramen ovale as an underlying factor. J Integr Neurosci. 2021;20(3):719–725. doi: 10.31083/j.jin2003077.
  43. Spiegel DR, Smith J, Wade RR, Cherukuru N, Ursani A, Dobruskina Y, Crist T, Busch RF, Dhanani RM, Dreyer N. Transient global amnesia: Current perspectives. Neuropsychiatr Dis Treat. 2017;13:2691–2703. doi: 10.2147/NDT.S130710.
  44. Jovanovic ZB, Pavlovic AM, Vujisic Tesic BP, Pekmezovic TP, Kostic Boricic MV, Cvitan EZ, Covickovic Sternic NM. Comprehensive ultrasound assessment of the craniocervical circulation in transient global amnesia. J Ultrasound Med. 2017;37(2):479–486. doi: 10.1002/jum.14355.
  45. McCabe AM, Platek NM, Palmieri JR, Foerst JR. Stroke-like symptoms during sexual intercourse in a 25-year-old female with a patent foramen ovale. Cureus. 2022;14(7):e27332. doi: 10.7759/cureus.27332.
  46. Sekarić J, Lučić-Prokin A, Zivanovc Z, Zekic-Kokai T, Lukić S, Gvozdenović S. Bilateral paramedian thalamic infarctions in a young woman with patent foramen ovale. Timočki medicinski glasnik. 2016;41(1):33–35. doi: 10.5937/tmg1601033S.
  47. Mazurkiewicz-Bełdzińska M, Szmuda M, Zawadzka M. Internuclear opthalmoplegia as a symptom of ischemic stroke in a girl with patent foramen ovale. Pediatr Neurol. 2015;52(4):466–467. doi: 10.1016/j.pediatrneurol.2014.12.007.
  48. Lyons LJ, Yarrabolu T, Kuffel RR, Bishop JE. Juvenile central retinal artery occlusion associated with atrial septal defect. J Pediatr Ophthalmol Strabismus. 2019;9(56):73–75. doi: 10.3928/01913913-20191016-01.

© 2024 Eco-Vector

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.




This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies